Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rademaker

Showing results (171-180 of 188) with videos related to

Pageof 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2014
Younger Dryas deglaciation of Scotland driven by warming summersGordon R M Bromley, Aaron E Putnam, Kurt M Rademaker, et al.
Cancer Chemotherapy and Pharmacology|September 22, 2006
Metabolism of trabectedin (ET-743, Yondelis) in patients with advanced cancerJan H Beumer, Jeany M Rademaker-Lakhai, Hilde Rosing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumorsJeany M Rademaker-Lakhai, Catherine Terret, Stephen B Howell, et al.
European Journal of Human Genetics : EJHG|April 1, 2004
Linkage disequilibrium in young genetically isolated Dutch populationYurii S Aulchenko, Peter Heutink, Ian Mackay, et al.
Breast Cancer Research and Treatment|November 30, 2019
The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancerAnouk K M Claessens, Reinier Timman, Jan J Busschbach, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 10, 2006
Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trialKeiichi Tsuchida, Héctor M García-García, Andrew T L Ong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancerJeany M Rademaker-Lakhai, Simon Horenblas, Willem Meinhardt, et al.
Journal of the American College of Cardiology|January 30, 2007
Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trialMarco Valgimigli, Keith Dawkins, Carlos Macaya, et al.
European Journal of Epidemiology|September 20, 2005
Phenotypic subtypes in attention deficit hyperactivity disorder in an isolated populationEsther A Croes, Rachid El Galta, Jeanine J Houwing-Duistermaat, et al.
Acta Oncologica (Stockholm, Sweden)|March 7, 2020
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancerAnouk K M Claessens, Frans L G Erdkamp, Marta Lopez-Yurda, et al.
Pageof 19

Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2014
Younger Dryas deglaciation of Scotland driven by warming summersGordon R M Bromley, Aaron E Putnam, Kurt M Rademaker, et al.
Cancer Chemotherapy and Pharmacology|September 22, 2006
Metabolism of trabectedin (ET-743, Yondelis) in patients with advanced cancerJan H Beumer, Jeany M Rademaker-Lakhai, Hilde Rosing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumorsJeany M Rademaker-Lakhai, Catherine Terret, Stephen B Howell, et al.
European Journal of Human Genetics : EJHG|April 1, 2004
Linkage disequilibrium in young genetically isolated Dutch populationYurii S Aulchenko, Peter Heutink, Ian Mackay, et al.
Breast Cancer Research and Treatment|November 30, 2019
The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancerAnouk K M Claessens, Reinier Timman, Jan J Busschbach, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 10, 2006
Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trialKeiichi Tsuchida, Héctor M García-García, Andrew T L Ong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancerJeany M Rademaker-Lakhai, Simon Horenblas, Willem Meinhardt, et al.
Journal of the American College of Cardiology|January 30, 2007
Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trialMarco Valgimigli, Keith Dawkins, Carlos Macaya, et al.
European Journal of Epidemiology|September 20, 2005
Phenotypic subtypes in attention deficit hyperactivity disorder in an isolated populationEsther A Croes, Rachid El Galta, Jeanine J Houwing-Duistermaat, et al.
Acta Oncologica (Stockholm, Sweden)|March 7, 2020
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancerAnouk K M Claessens, Frans L G Erdkamp, Marta Lopez-Yurda, et al.
Pageof 19